Scrotal cancer: Incidence, survival and second primary tumours in the Netherlands since 1989

Background: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. Methods: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. Results: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%),... Mehr ...

Verfasser: Verhoeven, R.H.A. (Rob)
Louwman, W.J.
Koldewijn, E.L. (Evert)
Demeyere, T.B.J. (Thomas)
Coebergh, J.W.W. (Jan Willem)
Dokumenttyp: Artikel
Erscheinungsdatum: 2010
Schlagwörter: Bowen disease / Netherlands / adult / aged / article / basal cell carcinoma / cancer incidence / cancer staging / cancer survival / carcinoma / human / incidence / major clinical study / male / neoplasms / primary tumor / priority journal / scrotum / scrotum cancer / second primary / squamous cell / squamous cell carcinoma / survival rate / testis cancer
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29199079
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/21641

Background: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. Methods: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. Results: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour. Conclusion: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers.